Autobahn Therapeutics is a clinical-stage biopharmaceutical company based in San Diego, California, developing regenerative medicines for central nervous system (CNS) disorders. The company pairs a proprietary brain-targeting chemistry platform - which creates orally administered small-molecule prodrugs designed to cross the blood-brain barrier… - View it on GitHub